Sign Up Today and Learn More About GeneMedicine Stock
Invest in or calculate the value of your shares in GeneMedicine or other pre-IPO companies through EquityZen, part of Morgan Stanley.
GeneMedicine Stock
GeneMedicine is a clinical stage biopharmaceutical company focused on developing next-generation viral immunotherapies.
About GeneMedicine Stock
Founded
2014
Industries
Natural Resources, Software, Artificial Intelligence
GeneMedicine Press Mentions
Stay in the know about the latest news on GeneMedicine
Anticancer composition comprising recombinant adenovirus expressing degradation …
patents • Mar 01, 2026
Gene delivery system containing relaxin gene and pharmaceutical composition …
patents • Mar 01, 2026
Anticancer Composition Comprising Tumor-Specific Oncolytic Adenovirus And …
patents • May 04, 2025
Anticancer Composition Comprising Tumor-Specific Oncolytic Adenovirus And …
patents • Apr 02, 2025
Key Market Driver In Oncolytic Adenovirus Industry 2025: Surge In Cancer Diagnoses Drives Breakthroughs
einpresswire • Mar 27, 2025
GeneMedicine Management
Leadership team at GeneMedicine
CEO
Chae-Ok Yun
Advisor
Noriyuki Noriyuki Kasahara
Join now and verify your accreditation status to gain access to:
- GeneMedicine Current Valuation
- GeneMedicine Stock Price
- GeneMedicine Management
- Available deals in GeneMedicine and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- GeneMedicine Cap Table and Funding History by Share Class and Liquidity Preferences
- GeneMedicine Revenue and Financials
- GeneMedicine Highlights
- GeneMedicine Business Model
- GeneMedicine Risk Factors
- GeneMedicine Research Report from SACRA Research
Trading GeneMedicine Stock
How to invest in GeneMedicine stock?
Accredited investors can buy pre-IPO stock in companies like GeneMedicine through EquityZen funds. These investments are made available by existing GeneMedicine shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process for buying Pre-IPO Shares.
How to sell GeneMedicine stock?
Shareholders can sell their GeneMedicine stock through EquityZen's private company marketplace. EquityZen's network includes over 470K accredited investors interested in buying private company stock. Learn more about the Shareholder liquidity process.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. See more information on Express Deals and pre-IPO exit information.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 55K private placements completed across 500+ companies, EquityZen leads the way in delivering "Private Markets for the Public."